胎IGF2BP3介导的微RNA结构多样性的控制在早期肺腺癌癌的恶性瘤
Yuko Fujiwara1, Ryou-U Takahashi2, Motonobu Saito3
1Laboratory of Molecular Carcinogenesis, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
概括
胎IGF2BP3蛋白控制微RNA (miRNA) 的结构多样性,影响肺腺癌 (LUAD) 复发风险. 这种蛋白调节特定的miRNA 3'-同位素 (3'-同位素Rs),创建癌症特异的基因表达特征和早期LUAD的预测D-score.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 遗传学 遗传学 是一个
背景情况:
- 由于结构多样性,癌症中的微RNA (miRNA) 功能障碍是复杂的.
- 特定miRNA异型在致癌过程中的作用尚未完全理解.
研究的目的:
- 研究子宫内IGF2BP3如何影响小RNA结构多样性.
- 确定IGF2BP3调节的miRNA异型对肺腺癌 (LUAD) 进展和复发的影响.
- 评估一种新型生物标志物的临床实用性,D分数,在早期的LUAD.
主要方法:
- 通过IGF2BP3.3调节的miRNA 3 -异形生成的分析.
- 细胞种子占用率和基因表达特征的评估.
- 在LUAD患者中,D-分数与临床复发风险和分子特征的相关性.
- 研究IGF2BP3在Drosha复合体和miRNA处理中的作用.
主要成果:
- IGF2BP3选择性地产生3 - 同位素 (例如,miR-21-5p,Let-7家族),改变种子占用率和基因表达.
- D-分数反映了miR-21-5p+C的主导地位,预测了早期LUAD的复发风险.
- IGF2BP3调节miR-21-5p,miR-425-5p和miR-454-3p,影响p53,TGF-β和TNF通路.
- 抑制IGF2BP3增加了Let-7 3 - isomiRs,抑制细胞循环基因.
结论:
- IGF2BP3对miRNA结构多样性的异常调节对于LUAD的发展至关重要.
- 通过IGF2BP3介导的3 - 异构体的产生建立了癌症特异性的基因表达特征.
- D-分数显示了作为早期LUAD风险分层的生物标志物的潜力.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Genomic Imprinting and Inheritance
34.2K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
34.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K


